本页面由Tiger Trade Technology Pte. Ltd.提供服务

Aldeyra Therapeutics Inc

1.80
-0.0300-1.64%
盘后1.77-0.0300-1.67%17:27 EDT
成交量:130.92万
成交额:231.09万
市值:1.08亿
市盈率:-3.19
高:1.83
开:1.82
低:1.71
收:1.83
52周最高:6.18
52周最低:1.07
股本:6,016.28万
流通股本:4,848.15万
量比:0.64
换手率:2.70%
股息:- -
股息率:- -
每股收益(TTM):-0.5636
每股收益(LYR):-0.5636
净资产收益率:-58.73%
总资产收益率:-24.95%
市净率:2.45
市盈率(LYR):-3.19

数据加载中...

2024/03/28

重要事件披露

Form 8-K - Current report
2024/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/07

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/07

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/13

重要事件披露

Form 8-K - Current report
2024/01/04

重要事件披露

Form 8-K - Current report
2023/12/22

重要事件披露

Form 8-K - Current report
2023/12/19

重要事件披露

Form 8-K - Current report
2023/11/28

重要事件披露

Form 8-K - Current report
2023/11/04

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/11/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/01

重要事件披露

Form 8-K - Current report
2023/10/19

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/10/16

重要事件披露

Form 8-K - Current report